Ajmaline

This classification denotes an antiarrhythmic agent with the molecular formula C20H26N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1PON08459R, chemically known as ajmalan-17,21-diol, (17r,21.alpha.)- but more generally known as ajmaline, which bears US NIH Compound Identifier 2073. Ajmaline comes in many forms, including aspartate, ethanolate, ethylphenylbarbiturate, n-oxide, and phenylbarbiturate. European Medicines Agency schedules Ajmaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12754MIG. World Health Organization schedules ajmaline in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, AJMALINE remains US FDA's Preferred Term for this commodity. Ajmaline bears US NLM identifiers UMLS ID C0001888 and NCI Concept Code C83524. SMILES: OC1C23C(N(C4C3CCCC4)C)C3N4C(C1C(C3)C(C4O)CC)C2.